Tema Heart & Health ETF
Registrant
Tema ETF Trust
Class ticker
Net Assets
$51,915,425
Holdings
35
Latest Report
May 31, 2026
Net Assets Over Time
Holdings · 35
Export CSV
Only this fund's positions in US-listed stocks Equibles tracks are shown. Other
holdings — bonds, foreign securities, and cash — aren't listed yet, so the positions
below are a fraction of the fund's
$51,915,425 in net assets.
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Eli Lilly & Co | LLY | 5,413 | $5,981,365 | 11.52% | Long | EC | |
| UnitedHealth Group Inc | UNH | 7,159 | $2,722,639 | 5.24% | Long | EC | |
| Merck & Co Inc | MRK | 18,672 | $2,216,740 | 4.27% | Long | EC | |
| Thermo Fisher Scientific Inc | TMO | 4,185 | $2,061,154 | 3.97% | Long | EC | |
| Johnson & Johnson | JNJ | 8,274 | $1,864,380 | 3.59% | Long | EC | |
| Gilead Sciences Inc | GILD | 13,261 | $1,782,676 | 3.43% | Long | EC | |
| Revolution Medicines Inc | RVMD | 10,971 | $1,727,713 | 3.33% | Long | EC | |
| Vertex Pharmaceuticals Inc | VRTX | 3,398 | $1,520,741 | 2.93% | Long | EC | |
| Danaher Corp | DHR | 7,557 | $1,380,437 | 2.66% | Long | EC | |
| Abbott Laboratories | ABT | 15,809 | $1,353,250 | 2.61% | Long | EC | |
| Bridgebio Pharma Inc | BBIO | 20,327 | $1,346,867 | 2.59% | Long | EC | |
| Cytokinetics Inc | CYTK | 17,069 | $1,310,216 | 2.52% | Long | EC | |
| AbbVie Inc | ABBV | 5,714 | $1,244,052 | 2.40% | Long | EC | |
| Bristol-Myers Squibb Co | BMY | 18,939 | $1,082,932 | 2.09% | Long | EC | |
| Teva Pharmaceutical Industries | TEVA | 30,273 | $1,069,242 | 2.06% | Long | EC | |
| Dexcom Inc | DXCM | 13,512 | $996,375 | 1.92% | Long | EC | |
| Amgen Inc | AMGN | 2,946 | $992,183 | 1.91% | Long | EC | |
| Edwards Lifesciences Corp | EW | 10,488 | $906,897 | 1.75% | Long | EC | |
| McKesson Corp | MCK | 1,196 | $887,958 | 1.71% | Long | EC | |
| Regeneron Pharmaceuticals Inc | REGN | 1,408 | $865,610 | 1.67% | Long | EC | |
| Madrigal Pharmaceuticals Inc | MDGL | 1,519 | $755,353 | 1.45% | Long | EC | |
| Boston Scientific Corp | BSX | 15,285 | $738,418 | 1.42% | Long | EC | |
| Intuitive Surgical Inc | ISRG | 1,590 | $675,178 | 1.30% | Long | EC | |
| Alnylam Pharmaceuticals Inc | ALNY | 1,954 | $590,069 | 1.14% | Long | EC | |
| Arrowhead Pharmaceuticals Inc | ARWR | 7,240 | $564,068 | 1.09% | Long | EC | |
| Scholar Rock Holding Corp | SRRK | 9,647 | $475,597 | 0.92% | Long | EC | |
| Xenon Pharmaceuticals Inc | XENE | 8,393 | $459,349 | 0.88% | Long | EC | |
| Ionis Pharmaceuticals Inc | IONS | 5,599 | $428,324 | 0.83% | Long | EC | |
| Insulet Corp | PODD | 2,835 | $410,905 | 0.79% | Long | EC | |
| Insmed Inc | INSM | 3,449 | $368,733 | 0.71% | Long | EC | |
| Stoke Therapeutics Inc | STOK | 10,049 | $310,615 | 0.60% | Long | EC | |
| Viking Therapeutics Inc | VKTX | 8,538 | $279,534 | 0.54% | Long | EC | |
| MBX Biosciences Inc | MBX | 8,761 | $275,709 | 0.53% | Long | EC | |
| Intellia Therapeutics Inc | NTLA | 13,892 | $195,460 | 0.38% | Long | EC | |
| Structure Therapeutics Inc | GPCR | 4,583 | $180,295 | 0.35% | Long | EC |